323631313	323631313	CD	B-NP	O
|	|	NN	I-NP	O
VHO	VHO	NN	I-NP	O
|	|	NN	I-NP	O
34666873	34666873	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3881914	3881914	CD	B-NP	O
|	|	CC	I-NP	O
7/17/2006	7/17/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/21/2006	11/21/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/29/2006	1/29/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
SRADER	SRADER	NNP	B-NP	O
,	,	,	O	O
RONALD	RONALD	NNP	B-NP	O
C.	C.	NNP	I-NP	O
556-77-31-6	556-77-31-6	NNP	I-NP	O
Squite	Squite	NNP	I-NP	O
Ster	Ster	NNP	I-NP	O
Squite	Squite	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/19/06	8/19/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BILELLO	BILELLO	NNP	B-NP	O
,	,	,	O	O
AMOS	AMOS	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
PHOSLO	PHOSLO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
ACETATE	ACETATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1	1	CD	I-NP	O
GELCAP	GELCAP	NN	I-NP	O
=	=	SYM	B-VP	O
667	667	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
-RRB-	-RRB-	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
334	334	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
WITH	WITH	NN	B-NP	B-DNA
MEALS	MEALS	NN	I-NP	I-DNA
PLAVIX	PLAVIX	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	O	I-DNA
75	75	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
ADVAIR	ADVAIR	NNP	I-NP	I-DNA
DISKUS	DISKUS	NNP	I-NP	I-DNA
500/50	500/50	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
SCRENCI	SCRENCI	NNP	B-NP	O
,	,	,	O	O
EARNEST	EARNEST	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVAQUIN	LEVAQUIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
209964266	209964266	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/5/06	6/5/06	CD	B-NP	O
by	by	IN	B-PP	O
ZARCONE	ZARCONE	NNP	B-NP	O
,	,	,	O	O
FREDRICK	FREDRICK	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
LANTUS	LANTUS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
half	half	JJ	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
npo	npo	NN	B-NP	B-protein
;	;	:	O	O
LEVAQUIN	LEVAQUIN	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/27	6/27	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
14	14	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
PEARS	PEARS	NNP	B-NP	O
,	,	,	O	O
ERIC	ERIC	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	B-protein
aware	aware	JJ	I-NP	I-protein
FLAGYL	FLAGYL	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METRONIDAZOLE	METRONIDAZOLE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q8H	Q8H	NN	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
6/27	6/27	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14d	14d	JJ	I-NP	O
course	course	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-protein
NEPHROCAPS	NEPHROCAPS	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	I-protein
RX	RX	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
SEVELAMER	SEVELAMER	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
WITH	WITH	NNP	B-NP	O
MEALS	MEALS	NNP	I-NP	O
ULTRAM	ULTRAM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
by	by	IN	B-PP	O
BAUZA	BAUZA	NNP	B-NP	O
,	,	,	O	O
JONAH	JONAH	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MORPHINE	MORPHINE	NN	B-NP	O
SULFATE	SULFATE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
007567481	007567481	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
MORPHINE	MORPHINE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
Mechanical	Mechanical	JJ	B-NP	O
Soft/Nectar	Soft/Nectar	NN	I-NP	O
Consistency	Consistency	NN	I-NP	O
/	/	SYM	B-NP	O
Renal	Renal	JJ	I-NP	O
diet	diet	NN	I-NP	O
/	/	SYM	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
controlled	control	VBN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
wheelchair	wheelchair	NN	B-NP	O
bound	bind	VBD	B-VP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
5/06	5/06	CD	B-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
w/Dr	w/Dr	NN	I-NP	O
pawley	pawley	NN	I-NP	O
pcp	pcp	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
ETHER	ETHER	NN	B-NP	B-protein
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Heparin	Heparin	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
constipation	constipation	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
constipation	constipation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
recurrent	recurrent	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
MRSA	MRSA	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
headache	headache	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
headache	headache	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
charcot	charcot	NN	I-NP	O
marie	marie	NN	I-NP	O
tooth	tooth	NN	I-NP	O
disease	disease	NN	I-NP	O
hearing	hearing	NN	I-NP	O
loss	loss	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sensorineural	sensorineural	JJ	I-NP	O
hearing	hearing	NN	I-NP	O
loss	loss	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Cough	Cough	NN	B-NP	O
and	and	CC	O	O
purulent	purulent	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
49M	49M	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
ESRD	ESRD	NN	I-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
,	,	,	O	O
paraplegia	paraplegia	NN	B-NP	O
apparently	apparently	RB	B-ADVP	O
2/2	2/2	CD	B-NP	O
charcot-marie-tooth	charcot-marie-tooth	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
admitted	admit	VBN	B-VP	O
from	from	IN	B-PP	O
home	home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	O	O
purulent	purulent	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

Increasingly	Increasingly	RB	B-ADJP	O
unable	unable	JJ	I-ADJP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
ADLs	ADL	NNS	B-NP	B-protein
while	while	IN	B-SBAR	O
living	live	VBG	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
concerned	concern	VBD	B-VP	O
about	about	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
and	and	CC	I-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
charcot-marie-tooth	charcot-marie-tooth	NN	B-NP	O
.	.	.	O	O

ED	ED	VBN	B-NP	O
course	course	NN	I-NP	O
:	:	SYM	O	O
T	T	NN	B-NP	O
100.3	100.3	CD	I-NP	O
;	;	:	O	O
P	P	NN	B-NP	B-protein
105	105	CD	I-NP	I-protein
;	;	:	O	O
BP	BP	NN	B-NP	O
148/72	148/72	CD	I-NP	O
;	;	:	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
L.	L.	NNP	I-NP	O
PMH	PMH	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Morbid	Morbid	NNP	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
and	and	CC	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
3	3	CD	I-NP	O
L	L	NN	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
.	.	.	O	O

Charcot-marie-tooth	Charcot-marie-tooth	JJ	B-NP	O
c/b	c/b	NN	I-NP	O
paraplegia	paraplegia	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
.	.	.	O	O

Type	Type	NN	B-NP	O
2	2	CD	I-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
.	.	.	O	O

Cardiomyopathy	Cardiomyopathy	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
preserved	preserve	VBN	B-NP	O
EF	EF	NN	I-NP	O
~	~	NN	I-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
by	by	IN	B-PP	O
11/17	11/17	CD	B-NP	O
echo	echo	NN	I-NP	O
,	,	,	O	O
7	7	CD	B-NP	O
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
HTN	HTN	NN	I-NP	O
by	by	IN	B-PP	O
11/17	11/17	CD	B-NP	O
echo	echo	NN	I-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
9	9	CD	B-NP	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
depression	depression	NN	I-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
.	.	.	O	O

Asthma	Asthma	NNP	B-NP	O
,	,	,	O	O
11	11	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
.	.	.	O	O

H/o	H/o	NN	B-NP	O
recurrent	recurrent	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
and	and	CC	I-NP	O
h/o	h/o	NN	I-NP	O
MRSA	MRSA	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
,	,	,	O	O
13	13	CD	B-NP	O
.	.	.	O	O

Anemia	Anemia	NN	B-NP	O
of	of	IN	B-PP	O
CKD	CKD	NN	B-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
.	.	.	O	O

H/o	H/o	NN	B-NP	O
recurrent	recurrent	JJ	I-NP	O
UTIs	UTI	NNS	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
SULFA	SULFA	NN	B-NP	B-protein
,	,	,	O	O
ETHER	ETHER	NN	B-NP	B-protein
,	,	,	O	O
HEPARIN	HEPARIN	NNP	B-NP	O
HOME	HOME	NNP	I-NP	O
MEDS	MEDS	NNP	I-NP	O
:	:	:	O	O
*******	*******	SYM	B-NP	B-DNA
ADMISSION	ADMISSION	NN	I-NP	I-DNA
NOTABLES	NOTABLES	NN	I-NP	I-DNA
P	P	NN	I-NP	I-DNA
103	103	CD	I-NP	I-DNA
;	;	:	O	I-DNA
BP	BP	NN	B-NP	I-DNA
131/71	131/71	CD	I-NP	I-DNA
;	;	:	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
L	L	NN	I-NP	O
;	;	:	O	O
NAD	NAD	NN	B-NP	O
;	;	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
;	;	:	O	O
RRR	RRR	NN	B-NP	O
w/o	w/o	NN	I-NP	O
r/m/g	r/m/g	NN	I-NP	O
;	;	:	O	O
+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
,	,	,	O	O
ND/NT	ND/NT	NN	B-NP	B-protein
;	;	:	O	I-protein
A	A	DT	B-NP	I-protein
&	&	CC	I-NP	B-protein
O	O	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
*******	*******	SYM	B-VP	I-protein
CONSULTS	CONSULTS	NN	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PDj24092	PDj24092	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
*******	*******	SYM	B-NP	O
OVERALL	OVERALL	NN	I-NP	O
ASSESSMENT	ASSESSMENT	NN	I-NP	O
:	:	:	O	O
49M	49M	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
ESRD	ESRD	NN	I-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
paraplegia	paraplegia	NN	B-NP	O
2/2	2/2	CD	I-NP	O
charcot-marie-tooth	charcot-marie-tooth	JJ	I-NP	O
admitted	admit	VBN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	O	O
purulent	purulent	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
along	along	IN	B-PP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
recent	recent	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
reflux	reflux	VBP	B-VP	O
with	with	IN	B-PP	O
likely	likely	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
PNA	PNA	NN	I-NP	O
*******	*******	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Likely	Likely	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
PNA	PNA	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
daily	daily	JJ	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
flagy	flagy	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Aspiration	Aspiration	NN	B-NP	O
precautions	precaution	NNS	I-NP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
culture	culture	NN	I-NP	O
and	and	CC	O	O
gram	gram	NN	B-NP	O
stain	stain	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Resent	Resent	JJ	B-ADJP	O
on	on	IN	B-PP	O
10/2	10/2	CD	B-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
of	of	IN	B-PP	O
101	101	CD	B-NP	O
.	.	.	O	O

NGTD	NGTD	NN	B-NP	B-protein
Clinically	Clinically	RB	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
clinically	clinically	RB	B-ADVP	O
well	well	RB	I-ADVP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
Multifactorial	Multifactorial	JJ	B-NP	O
home	home	NN	I-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
from	from	IN	B-PP	O
OSA	OSA	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Has	Has	IN	B-PP	O
3	3	CD	B-NP	O
L	L	NN	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

CPAP	CPAP	NN	B-NP	B-protein
recommended	recommend	VBD	B-VP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
refused.Supportive	refused.Supportive	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Outpatient	Outpatient	NN	B-NP	O
PFTS	PFTS	NNS	I-NP	O
when	when	WRB	B-ADVP	O
pna	pna	NN	B-NP	O
resolved.Currently	resolved.Currently	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
02	02	CD	I-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CARDS	CARDS	NN	B-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
Euvolemic	Euvolemic	NNP	B-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
toprol	toprol	NN	I-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qdaily.Refusing	qdaily.Refusing	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

CARDS	CARDS	NN	B-NP	O
RHYTHM/ISCHEMIA	RHYTHM/ISCHEMIA	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Post-prandial	Post-prandial	JJ	B-NP	O
RUQ	RUQ	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

RUQ	RUQ	NN	B-NP	B-protein
U/S	U/S	NN	I-NP	I-protein
demonstrated	demonstrate	VBD	B-VP	O
fatty	fatty	JJ	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
overall	overall	JJ	B-NP	O
poor	poor	JJ	I-NP	O
study	study	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
habitus	habitus	NN	B-NP	O
.	.	.	O	O

Speech	Speech	NN	B-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
eval	eval	NN	B-NP	O
.	.	.	O	O

Video	Video	NNP	B-NP	O
swallow	swallow	VBP	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
complete	complete	JJ	B-ADJP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

Fiberoptic	Fiberoptic	JJ	B-NP	O
study	study	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
any	any	DT	B-NP	O
vocal	vocal	JJ	I-NP	O
cord	cord	NN	I-NP	O
paralysis.Bedside	paralysis.Bedside	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
diaphramatic	diaphramatic	JJ	B-NP	O
function	function	NN	I-NP	O
bid	bid	NN	I-NP	O
by	by	IN	B-PP	O
respiratory	respiratory	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Paraplegia	Paraplegia	NNP	B-NP	O
2/2	2/2	CD	B-NP	O
charcot-marie-tooth	charcot-marie-tooth	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
consulted	consult	VBD	B-VP	O
.	.	.	O	O

Recommended	Recommend	VBN	B-NP	O
further	further	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
to	to	TO	B-VP	O
r/o	r/o	VB	I-VP	O
cord	cord	NN	B-NP	O
involvement	involvement	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-PP	O
complete	complete	JJ	B-NP	O
Ct	Ct	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
habitus	habitus	NN	B-NP	O
,	,	,	O	O
refusing	refuse	VBG	B-VP	O
MRI	MRI	NN	B-NP	B-protein
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

PSYCH	PSYCH	NN	B-NP	B-protein
:	:	:	O	O
Ativan	Ativan	IN	B-PP	O
prn	prn	NN	B-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
consult	consult	NN	I-NP	O
refused	refuse	VBD	B-VP	O
.	.	.	O	O

Awaiting	Await	VBG	B-VP	O
social	social	JJ	B-NP	O
work	work	NN	I-NP	O
eval	eval	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
states	state	VBZ	B-VP	O
he	he	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
safe	safe	JJ	B-ADJP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
.8	.8	CD	I-NP	I-DNA
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
PPI	PPI	NN	B-NP	B-protein
.	.	.	O	O

Holding	Hold	VBG	B-VP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
desquamating	desquamate	VBG	B-VP	O
rash	rash	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
PCP	PCP	NN	I-NP	O
Sandell	Sandell	NNP	B-NP	O
141-542-7001	141-542-7001	CD	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-NP	O
complete	complete	JJ	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
course	course	NN	I-NP	O
complete	complete	JJ	I-NP	O
regular	regular	JJ	I-NP	O
dialysis	dialysis	NN	I-NP	O
as	as	IN	B-PP	O
sceduled	sceduled	JJ	B-NP	O
reutn	reutn	NN	I-NP	O
to	to	TO	B-PP	O
Ed	Ed	NNP	B-NP	O
with	with	IN	B-PP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SUSANA	SUSANA	NNP	B-NP	O
,	,	,	O	O
JAMAR	JAMAR	NNP	B-NP	B-protein
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NM201	NM201	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/19/06	8/19/06	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
29	29	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

